Risultati della ricerca - Michael J. Elman
- Mostra 1 - 20 risultati su 26
- Vai alla pagina seguente
-
1
Thrombolytic therapy for central retinal vein occlusion: results of a pilot study di THOMAS J. LIESEGANG, Michael J. Elman
Pubblicazione 1997Artigo -
2
-
3
-
4
-
5
-
6
-
7
Observational Study of the Development of Diabetic Macular Edema Following Panretinal (Scatter) Photocoagulation Given in 1 or 4 Sittings di Brucker Aj, Hong Qin, Antoszyk An, Beck Rw, Bressler Nm, Browning DJ, Michael J. Elman, Adam R. Glassman, Gross Jg, Craig Kollman, Wells Ja
Pubblicazione 2009Artigo -
8
Dexamethasone Implant Anterior Chamber Migration di Rahul N. Khurana, Suri N. Appa, Colin A. McCannel, Michael J. Elman, Susan E. Wittenberg, David J. Parks, Saad Ahmad, Steven Yeh
Pubblicazione 2013Artigo -
9
Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results di Michael J. Elman, Allison R. Ayala, Neil M. Bressler, David J. Browning, Christina J. Flaxel, Adam R. Glassman, Lee M. Jampol, Thomas W. Stone
Pubblicazione 2014Artigo -
10
-
11
Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) Study di Emily Y. Chew, Traci E. Clemons, Susan B. Bressler, Michael J. Elman, Ronald P. Danis, Amitha Domalpally, Jeffrey S. Heier, Judy E. Kim, Richard A. Garfinkel
Pubblicazione 2013Artigo -
12
-
13
Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study) di Adam R. Glassman, John A. Wells, Kristin Josic, Maureen G. Maguire, Andrew N. Antoszyk, Carl W. Baker, Wesley T. Beaulieu, Michael J. Elman, Lee M. Jampol, Jennifer K. Sun
Pubblicazione 2020Artigo -
14
Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema di Michael J. Elman, Neil M. Bressler, Haijing Qin, Roy W. Beck, Frederick L. Ferris, Scott M. Friedman, Adam R. Glassman, Ingrid U. Scott, Cynthia R. Stockdale, Jennifer K. Sun
Pubblicazione 2011Artigo -
15
A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular Edema di Ingrid U. Scott, Allison R. Edwards, Roy W. Beck, Neil M. Bressler, Clement K. Chan, Michael J. Elman, Scott M. Friedman, Craig M. Greven, Raj K. Maturi, Dante J. Pieramici, Michel Shami, Lawrence J. Singerman, Cynthia R. Stockdale
Pubblicazione 2007Artigo -
16
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema di Michael J. Elman, Lloyd Paul Aiello, Roy W. Beck, Neil M. Bressler, Susan B. Bressler, Allison R. Edwards, Frederick L. Ferris, Scott M. Friedman, Adam R. Glassman, David Miller, Ingrid U. Scott, Cynthia R. Stockdale, Jennifer K. Sun
Pubblicazione 2010Artigo -
17
Retinal Thickness on Stratus Optical Coherence Tomography in People with Diabetes and Minimal or No Diabetic Retinopathy di Neil M. Bressler, Allison R. Edwards, Andrew N. Antoszyk, Roy W. Beck, David J. Browning, Antonio P. Ciardella, Ronald P. Danis, Michael J. Elman, Scott M. Friedman, Adam R. Glassman, Jeffrey G. Gross, Helen K. Li, T. Murtha, Thomas W. Stone, Jennifer K. Sun
Pubblicazione 2008Artigo -
18
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy di Jeffrey G. Gross, Adam R. Glassman, Danni Liu, Jennifer K. Sun, Andrew N. Antoszyk, Carl W. Baker, Neil M. Bressler, Michael J. Elman, Frederick L. Ferris, Thomas W. Gardner, Lee M. Jampol, Daniel Martín, Michele Melia, Cynthia R. Stockdale, Roy W. Beck
Pubblicazione 2018Artigo -
19
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema di John A. Wells, Adam R. Glassman, Lee M. Jampol, Lloyd Paul Aiello, Andrew N. Antoszyk, Carl W. Baker, Neil M. Bressler, David J. Browning, Crystal G. Connor, Michael J. Elman, Frederick L. Ferris, Scott M. Friedman, Michele Melia, Dante J. Pieramici, Jennifer K. Sun, Roy W. Beck
Pubblicazione 2015Artigo -
20
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema di John A. Wells, Adam R. Glassman, Allison R. Ayala, Lee M. Jampol, Lloyd Paul Aiello, Andrew N. Antoszyk, Bambi J. Arnold-Bush, Carl W. Baker, Neil M. Bressler, David J. Browning, Michael J. Elman, Frederick L. Ferris, Scott M. Friedman, Michele Melia, Dante J. Pieramici, Jennifer K. Sun, Roy W. Beck
Pubblicazione 2015Artigo
Strumenti per la ricerca:
Soggetti correlati
Medicine
Ophthalmology
Visual acuity
Diabetes mellitus
Endocrinology
Diabetic retinopathy
Surgery
Internal medicine
Bevacizumab
Chemotherapy
Diabetic macular edema
Macular edema
Ranibizumab
Randomized controlled trial
Optometry
Retinal
Clinical trial
Macular degeneration
Aflibercept
Biology
Confidence interval
Edema
Carotenoid
Central retinal vein occlusion
Fluorescein angiography
Laser coagulation
Lutein
Observational study
Occlusion
Optical coherence tomography